These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 20441418)

  • 1. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2).
    Krassilnikova S; Craig ET; Craig TJ
    Expert Rev Clin Immunol; 2010 May; 6(3):327-34. PubMed ID: 20441418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
    Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
    Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
    Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week.
    Bork K; Hardt J
    Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.
    Hofstra JJ; Kleine Budde I; van Twuyver E; Choi G; Levi M; Leebeek FW; de Monchy JG; Ypma PF; Keizer RJ; Huitema AD; Strengers PF
    Clin Immunol; 2012 Mar; 142(3):280-90. PubMed ID: 22197071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
    Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
    J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
    Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
    Lunn ML; Santos CB; Craig TJ
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):211-4. PubMed ID: 20377110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M
    Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
    Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registry.
    Busse P; Bygum A; Edelman J; Lumry W; Machnig T; Martinez-Saguer I; Rojavin M
    J Allergy Clin Immunol Pract; 2015; 3(2):213-9. PubMed ID: 25609333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.